Human Neuropilin-1 Antibody, R&D Systems™

Neuropilin-1

Polyclonal

Western Blot 1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, Blockade of Receptor-ligand Interaction 0.25-1 ug/mL, Immunocytochemistry 5-15 ug/mL, CyTOF-ready

NP_001019799

NRP1

Mouse myeloma cell line NS0-derived recombinant human Neuropilin-1 Phe22-Lys644 Accession # NP_001019799

25 μg

Primary

Detects human Neuropilin-1 in direct ELISAs and Western blots. In direct ELISAs, less than 50% cross-reactivity with recombinant rat Neuropilin-1 and recombinant mouse Neuropilin-1 is observed, and less than 1% cross-reactivity with recombinant human Neuropilin-2 is observed.

Human

IgG

Western Blot, Flow Cytometry, Immunohistochemistry, Blockade of Receptor-ligand Interaction, Immunocytochemistry

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. with No Preservative

BDCA4, BDCA-4, CD304, CD304 antigen, DKFZp686A03134, DKFZp781F1414, neuropilin 1, neuropilin-1, Neuropilin1, NP1, NRP, NRP1, transmembrane receptor, Vascular endothelial cell growth factor 165 receptor, VEGF165R

Sheep

Affinity Purified

RUO

8829

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.